702 related articles for article (PubMed ID: 20055701)
1. LPA receptors: subtypes and biological actions.
Choi JW; Herr DR; Noguchi K; Yung YC; Lee CW; Mutoh T; Lin ME; Teo ST; Park KE; Mosley AN; Chun J
Annu Rev Pharmacol Toxicol; 2010; 50():157-86. PubMed ID: 20055701
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) and its receptors.
Noguchi K; Herr D; Mutoh T; Chun J
Curr Opin Pharmacol; 2009 Feb; 9(1):15-23. PubMed ID: 19119080
[TBL] [Abstract][Full Text] [Related]
3. LPA receptor signaling: pharmacology, physiology, and pathophysiology.
Yung YC; Stoddard NC; Chun J
J Lipid Res; 2014 Jul; 55(7):1192-214. PubMed ID: 24643338
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.
Lin ME; Herr DR; Chun J
Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):130-8. PubMed ID: 20331961
[TBL] [Abstract][Full Text] [Related]
6. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
Hama K; Aoki J
Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.
Zhou Y; Little PJ; Ta HT; Xu S; Kamato D
Pharmacol Ther; 2019 Dec; 204():107404. PubMed ID: 31472182
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
9. The Japanese lamprey (Lethenteron camtschaticum) expresses functional lysophosphatidic acid receptors.
Tamaki T; Kagawa N; Fukushima N
Biochem Biophys Res Commun; 2021 Sep; 568():1-7. PubMed ID: 34166971
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.
Dacheux MA; Norman DD; Tigyi GJ; Lee SC
Pharmacol Ther; 2023 May; 245():108414. PubMed ID: 37061203
[TBL] [Abstract][Full Text] [Related]
11. Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
Fukushima N; Ishii S; Tsujiuchi T; Kagawa N; Katoh K
Cell Mol Life Sci; 2015 Jun; 72(12):2377-94. PubMed ID: 25732591
[TBL] [Abstract][Full Text] [Related]
12. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
13. [Lysophosphatidic acid receptors and the downstream signaling pathways in regulation of cardiac cell growth].
Chen X
Sheng Li Xue Bao; 2007 Oct; 59(5):619-27. PubMed ID: 17940702
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
Valdés-Rives SA; González-Arenas A
Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.
Ye X; Chun J
Trends Endocrinol Metab; 2010 Jan; 21(1):17-24. PubMed ID: 19836970
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid, a simple phospholipid with myriad functions.
Yanagida K; Shimizu T
Pharmacol Ther; 2023 Jun; 246():108421. PubMed ID: 37080433
[TBL] [Abstract][Full Text] [Related]
18. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
19. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
20. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
Jenkin KA; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
